Início › Câncer de Pulmão › Utah › Salt Lake City
Ensaios clínicos de Câncer de Pulmão em Salt Lake City, UT
21 estudos para Câncer de Pulmão estão buscando participantes em locais em Salt Lake City e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
RecrutandoFase 3
- Utah Cancer Specialists, Salt Lake City
- Huntsman Cancer Institute, Salt Lake City
SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- University of Utah, Salt Lake City
- Veterans Affairs SLC Health Care System (VAMC), Salt Lake City
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RecrutandoFase 3
- Huntsman Cancer Institute ( Site 0042), Salt Lake City
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecrutandoFase 3
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
RecrutandoFase 2/3
- Huntsman Cancer Institute, Salt Lake City
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
RecrutandoFase 2/3
- Utah Cancer Specialists, Salt Lake City
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
RecrutandoFase 1
- Huntsman Cancer Institute, Salt Lake City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RecrutandoFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
RecrutandoVoluntários saudáveis bem-vindos
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecrutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecrutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RecrutandoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2/3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecrutandoFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recrutando
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecrutandoFase 1/2
- University of Utah, Huntsman Cancer Institute, Salt Lake City
Improving Care for Rural Patients With Solid Tumors
Recrutando
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecrutandoFase 1/2
- Utah Cancer Specialists (site 203), Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
Ensaios de Câncer de Pulmão em outras cidades
- Houston, TX78 estudos
- Boston, MA62 estudos
- New York City, NY60 estudos
- Los Angeles, CA45 estudos
- Arlington, VA41 estudos
- Washington, DC41 estudos
- Chicago, IL41 estudos
- Baltimore, MD40 estudos
- Nashville, TN40 estudos
- St. Louis, MO39 estudos
- Columbus, OH37 estudos
- Philadelphia, PA36 estudos
Outros estudos em Salt Lake City
- Câncer de Pulmão de Não Pequenas Células31 estudos
- Câncer (todos os tipos)27 estudos
- Câncer de Mama27 estudos
- Câncer Colorretal22 estudos
- Melanoma21 estudos
- Mieloma Múltiplo21 estudos
- Câncer Metastático20 estudos
- Câncer de Ovário19 estudos
- Obesidade18 estudos
- Leucemia Mieloide Aguda17 estudos
- Insuficiência Cardíaca17 estudos
- Câncer de Próstata15 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.